Bob Oliver sold $1.3M of EXEL
director at EXELIXIS, INC.. 30,250 shares at an average of $43.81, traded Feb 13, 2026, filed Feb 18, 2026.
Score components
- +15RoleDirector
- +25Trade size$1.3M at market
- +20Share of holdings soldSold 59% of holdings
- +15Cluster8 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000939767-26-000023, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | MOption exercise Common Stock | +9,088 | $19.28 | $175k | 51,370 | Feb 18, 2026 |
| Feb 13, 2026 | SOpen-market sale Common Stock | -9,088 | $43.61 | $396k | 42,282 | Feb 18, 2026 |
| Feb 13, 2026 | SOpen-market sale Common Stock | -21,162 | $43.90 | $929k | 21,120 | Feb 18, 2026 |
| Feb 13, 2026 | MOption exercise Option (right to buy)derivative | -9,088 | $0.00 | $0 | 12,118 | Feb 18, 2026 |
Related signals
Other insiders at EXELIXIS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | EXELIXIS, INC. | Dana Aftab EVP, Research and Development | $2.1M 47,918 shares | -7% | |
| 55Moderate | EXELIXIS, INC. | Dana Aftab EVP, Research and Development | $1.3M 29,873 shares | -4% | |
| 30Weak | EXELIXIS, INC. | Jack L Wyszomierski director | $4.4M 99,574 shares | -26% | |
| 60Notable | EXELIXIS, INC. | Julie Smith director | $4.7M 106,539 shares | -169% | |
| 38Weak | EXELIXIS, INC. | Brenda Hefti SVP and General Counsel | $822k 18,669 shares | -16% | |
| 26Weak | EXELIXIS, INC. | Sue Gail Eckhardt director | $169k 3,856 shares | -18% | |
| 60Notable | EXELIXIS, INC. | Patrick J. Haley EVP, Commercial | $3.0M 67,814 shares | -15% | |
| 62Notable | EXELIXIS, INC. | Christopher J. Senner EVP and CFO | $2.8M 64,895 shares | -6% | |
| 40Moderate | EXELbuy EXELIXIS, INC. | David Edward Johnson director | $1.2M 27,532 shares | +2% | |
| 60Notable | EXELIXIS, INC. | Patrick J. Haley EVP, Commercial | $3.0M 72,230 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.